L J J Derijks

Publication Activity (10 Years)

Years Active: 2017-2017
Publications (10 Years): 3

Top Topics

Patients With Inflammatory Bowel Disease

Rheumatoid Arthritis Patients

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

E M H Schmitz, S Benoy-De Keuster, A J L Meier, V Scharnhorst, R A M Traksel, M A C Broeren, L J J Derijks
Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study. Clinical rheumatology 36 (9) (2017)
M M T J Broekman, M J H Coenen, G J Wanten, C J van Marrewijk, O H Klungel, A L M Verbeek, P M Hooymans, H-J Guchelaar, H Scheffer, L J J Derijks, Dennis R Wong, D J de Jong
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype. Alimentary pharmacology & therapeutics 46 (10) (2017)
E M H Schmitz, P J Boekema, J W A Straathof, D C van Renswouw, L Brunsveld, V Scharnhorst, M E C van de Poll, M A C Broeren, L J J Derijks
Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study. Alimentary pharmacology & therapeutics 47 (3) (2017)